Peregrine Pharmaceuticals (NASDAQ: PPHM ) today announced that it has received a letter from The NASDAQ Stock Market LLC notifying the company that it has regained full compliance with the NASDAQ Capital Market's minimum bid price continued listing requirement. The letter received today noted that as of December 10,